Skip to main content

Advertisement

SpringerLink
Log in

Hodgkin Disease Therapy Induced Second Malignancy Susceptibility 6q21 Functional Variants in Roma and Hungarian Population Samples

  • Research
  • Published:
Pathology & Oncology Research

Abstract

Patients treated successfully for pediatric Hodgkin’s lymphoma are known to develop secondary malignancies; care is already taken in treatment to prevent this adverse effect. Recent GWAS study identified rs4946728 and rs1040411 noncoding SNPs located between PRDM1 and ATG1 genes on chromosome 6q21 as risk factors for secondary malignancies in patients formerly treated with radiotherapy for pediatric Hodgkin disease. We investigated the allele frequencies of these two SNPs in biobanked, randomly selected DNA of average, apparently healthy Hungarians (n = 277) and in samples of Roma (n = 279) population living Hungary. The risk allele frequency for rs4946728 was 79.4 % in Hungarian and 83.5 % in Roma samples, while for rs1040411 it was 56.4 % in Hungarian and 55.8 % in Roma samples. These values are quite similar in the two populations, and are rather high. The values are higher than those frequencies observed in the controls (rs4946728: 59.1 % and rs1040411: 39.6 %, p < 0.05), and are in the range of the cases (86 % and 68.2 %, respectively) of the above original GWAS study. Our findings suggest, that beside the already taken precautions, genetic characterization of Hungarian pediatric Hodgkin patients seems to be advantageous prior to the treatment of their disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL, Neglia JP (2010) Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 102:1083–1095

    Article  PubMed Central  PubMed  Google Scholar 

  2. Meadows AT, Friedman DL, Neglia JP, Mertens AC, Donaldson SS, Stovall M, Hammond S, Yasui Y, Inskip PD (2009) Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort. J Clin Oncol 27:2356–2362

    Article  PubMed Central  PubMed  Google Scholar 

  3. O’Brien MM, Donaldson SS, Balise RR, Whittemore AS, Link MP (2010) Second malignant neoplasms in survivors of pediatric Hodgkin’s lymphoma treated with low-dose radiation and chemotherapy. J Clin Oncol 28:1232–1239

    Article  PubMed  Google Scholar 

  4. Best T, Li D, Skol AD, Kirchhoff T, Jackson SA, Yasui Y, Bhatia S, Strong LC, Domchek SM, Nathanson KL, Olopade OI, Huang RS, Mack TM, Conti DV, Offit K, Cozen W, Robison LL, Onel K (2011) Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin’s lymphoma. Nat Med 17:941–943

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  5. Keller AD, Maniatis T (1991) Identification and characterization of a novel repressor of beta-interferon gene expression. Genes Dev 5:868–879

    Article  CAS  PubMed  Google Scholar 

  6. Shaffer AL, Lin KI, Kuo TC, Yu X, Hurt EM, Rosenwald A, Giltnane JM, Yang L, Zhao H, Calame K, Staudt LM (2002) Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17:51–62

    Article  CAS  PubMed  Google Scholar 

  7. Shapiro-Shelef M, Calame K (2005) Regulation of plasma-cell development. Nature reviews. Immunology 5:230–242

    CAS  PubMed  Google Scholar 

  8. Chang DH, Angelin-Duclos C, Calame K (2000) BLIMP-1: trigger for differentiation of myeloid lineage. Nat Immunol 1:169–176

    Article  CAS  PubMed  Google Scholar 

  9. Yan J, Jiang J, Lim CA, Wu Q, Ng HH, Chin KC (2007) BLIMP1 regulates cell growth through repression of p53 transcription. Proc Natl Acad Sci U S A 104:1841–1846

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Lin FR, Kuo HK, Ying HY, Yang FH, Lin KI (2007) Induction of apoptosis in plasma cells by B lymphocyte-induced maturation protein-1 knockdown. Cancer Res 67:11914–11923

    Article  CAS  PubMed  Google Scholar 

  11. Nadasi E, Gyurus P, Czako M, Bene J, Kosztolanyi S, Fazekas S, Domosi P, Melegh B (2007) Comparison of mtDNA haplogroups in Hungarians with four other European populations: a small incidence of descents with Asian origin. Acta Biol Hung 58:245–256

    Article  PubMed  Google Scholar 

  12. Semino O, Passarino G, Quintana-Murci L, Liu A, Beres J, Czeizel A, Santachiara-Benerecetti AS (2000) MtDNA and Y chromosome polymorphisms in Hungary: inferences from the palaeolithic, neolithic and Uralic influences on the modern Hungarian gene pool. Eur J Hum Genet 8:339–346

    Article  CAS  PubMed  Google Scholar 

  13. Tomory G, Csanyi B, Bogacsi-Szabo E, Kalmar T, Czibula A, Csosz A, Priskin K, Mende B, Lango P, Downes CS, Rasko I (2007) Comparison of maternal lineage and biogeographic analyses of ancient and modern Hungarian populations. Am J Phys Anthropol 134:354–368

    Article  PubMed  Google Scholar 

  14. Sipeky C, Lakner L, Szabo M, Takacs I, Tamasi V, Polgar N, Falus A, Melegh B (2009) Interethnic differences of CYP2C9 alleles in healthy Hungarian and Roma population samples: relationship to worldwide allelic frequencies. Blood Cells Mol Dis 43:239–242

    Article  CAS  PubMed  Google Scholar 

  15. Sipeky C, Csongei V, Jaromi L, Safrany E, Polgar N, Lakner L, Szabo M, Takacs I, Melegh B (2009) Vitamin K epoxide reductase complex 1 (VKORC1) haplotypes in healthy Hungarian and Roma population samples. Pharmacogenomics 10:1025–1032

    Article  CAS  PubMed  Google Scholar 

  16. Kalaydjieva L, Gresham D, Calafell F (2001) Genetic studies of the Roma (Gypsies): a review. BMC Medical Genetics 2:5

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Bombard Y, Abelson J, Simeonov D, Gauvin FP (2013) Citizens’ perspectives on personalized medicine: a qualitative public deliberation study. Eur J Hum Genet

  18. Emmert-Streib F (2012) Personalized medicine: Has it started yet? A reconstruction of the early history. Front Genet 3:313

    Article  PubMed Central  PubMed  Google Scholar 

  19. Grosse SD, Khoury MJ (2006) What is the clinical utility of genetic testing? Genetics in Med: Off J Am College of Med Genetics 8:448–450

    Article  Google Scholar 

  20. Pasic MD, Samaan S, Yousef GM (2013) Genomic medicine: new frontiers and new challenges. Clin Chem 59:158–167

    Article  CAS  PubMed  Google Scholar 

  21. Marshall E (2011) Human genome 10th anniversary. Waiting for the revolution. Science 331:526–529

    Article  CAS  PubMed  Google Scholar 

  22. Behrens C, Travis LB, Wistuba II, Davis S, Maitra A, Clarke EA, Lynch CF, Glimelius B, Wiklund T, Tarone R, Gazdar AF (2000) Molecular changes in second primary lung and breast cancers after therapy for Hodgkin’s disease. Cancer Epidemiology. Biomarkers and Prevention 9:1027–1035

    CAS  Google Scholar 

  23. Constine LS, Tarbell N, Hudson MM, Schwartz C, Fisher SG, Muhs AG, Basu SK, Kun LE, Ng A, Mauch P, Sandhu A, Culakova E, Lyman G, Mendenhall N (2008) Subsequent malignancies in children treated for Hodgkin’s disease: associations with gender and radiation dose. Int J Radiat Oncol Biol Phys 72:24–33

    Article  PubMed Central  PubMed  Google Scholar 

  24. Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, Donaldson SS, Meadows AT, Robison LL (2001) Second malignant neoplasms in 5-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 93:618–629

    Article  CAS  PubMed  Google Scholar 

  25. Robison LL, Green DM, Hudson M, Meadows AT, Mertens AC, Packer RJ, Sklar CA, Strong LC, Yasui Y, Zeltzer LK (2005) Long-term outcomes of adult survivors of childhood cancer. Cancer 104:2557–2564

    Article  PubMed  Google Scholar 

  26. Sipeky C, Csongei V, Jaromi L, Safrany E, Maasz A, Takacs I, Beres J, Fodor L, Szabo M, Melegh B (2011) Genetic variability and haplotype profile of MDR1 (ABCB1) in Roma and Hungarian population samples with a review of the literature. Drug Metababolism and Pharmacokinet 26:206–215

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by the grant of Hungarian Scientific Research Foundation, OTKA K 103983.

Author information

Authors and Affiliations

  1. Department of Dermatology, Venereology and Oncodermatology, University of Pecs, Pecs, Hungary

    Dalma Varszegi

  2. Department of Medical Genetics, and Szentágothai Research Center, University of Pecs, Pecs, Hungary

    Balazs Duga, Bela I. Melegh, Katalin Sumegi, Peter Kisfali, Anita Maasz & Bela Melegh

  3. Department of Medical Genetics, University of Pécs, Szigeti 12, 7624, Pécs, Hungary

    Bela Melegh

Authors
  1. Dalma Varszegi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Balazs Duga
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bela I. Melegh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Katalin Sumegi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Peter Kisfali
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Anita Maasz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Bela Melegh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bela Melegh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Varszegi, D., Duga, B., Melegh, B.I. et al. Hodgkin Disease Therapy Induced Second Malignancy Susceptibility 6q21 Functional Variants in Roma and Hungarian Population Samples. Pathol. Oncol. Res. 20, 529–533 (2014). https://doi.org/10.1007/s12253-013-9724-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-013-9724-z

Keywords

Search

Navigation